Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events

BACKGROUND: The cardiovascular (CV) safety of linagliptin was evaluated in subjects with type 2 diabetes (T2DM). METHODS: Pre-specified patient-level pooled analysis of all available double-blind, randomized, controlled trials, ≥12 weeks’ duration (19 trials, 9459 subjects) of linagliptin versus pla...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cardiovasc Diabetol
Main Authors: Rosenstock, Julio, Marx, Nikolaus, Neubacher, Dietmar, Seck, Thomas, Patel, Sanjay, Woerle, Hans-Juergen, Johansen, Odd Erik
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2015
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4465456/
https://ncbi.nlm.nih.gov/pubmed/25990013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-015-0215-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker